Primary Site >> Esophagus Cancer
Gene >> ERCC2
| 1. | |||||||||||
| Journal: | Oncol Rep. 2003 Sep-Oct;10(5):1615-23. | ||||||||||
| Title: | Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (review). | ||||||||||
| Author: | Xing, Deyin|Tan, Wen|Lin, Dongxin | ||||||||||
| PMID: | 12883749 | ||||||||||
| 2. | |||||||||||
| Journal: | Ann Surg. 2011 May;253(5):918-27. | ||||||||||
| Title: | Genetic variants in DNA repair predicts the survival of patients with esophageal cancer. | ||||||||||
| Author: | Lee, Jang-Ming|Yang, Pei-Wen|Yang, Shi-Yi|Chuang, Tzu-Hsuen|Tung, En-Chi|Chen, Jin-Shing|Huang, Pei-Ming|Lee, Yung-Chie | ||||||||||
| PMID: | 21490450 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Biol Rep. 2012 Mar;39(3):2533-40. | ||||||||||
| Title: | XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. | ||||||||||
| Author: | Ding, Da-Peng|Ma, Wen-Li|He, Xiao-Feng|Zhang, Ying | ||||||||||
| PMID: | 21667112 | ||||||||||
| 4. | |||||||||||
| Journal: | Asian Pac J Cancer Prev. 2012;13(7):3299-303. | ||||||||||
| Title: | Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. | ||||||||||
| Author: | Duan, Xiao-Li|Gong, Heng|Zeng, Xian-Tao|Ni, Xiao-Bing|Yan, Yan|Chen, Wen|Liu, Guo-Lei | ||||||||||
| PMID: | 22994751 | ||||||||||
| 5. | |||||||||||
| Journal: | Pharmacogenet Genomics. 2013 Nov;23(11):597-604. | ||||||||||
| Title: | ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. | ||||||||||
| Author: | Rumiato, Enrica|Cavallin, Francesco|Boldrin, Elisa|Cagol, Matteo|Alfieri, Rita|Basso, Daniela|Castoro, Carlo|Ancona, Ermanno|Amadori, Alberto|Ruol, Alberto|Saggioro, Daniela | ||||||||||
| PMID: | 23962907 | ||||||||||
| 6. | |||||||||||
| Journal: | Tumour Biol. 2014 Apr;35(4):2959-65. | ||||||||||
| Title: | A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility. | ||||||||||
| Author: | Wen, Fang|Zhao, Zhiyong|Liu, Chuan|Yin, Qinghua|Weng, Jie|Wang, Yajie|Ma, Yuchen | ||||||||||
| PMID: | 24234258 | ||||||||||
| 7. | |||||||||||
| Journal: | Tumour Biol. 2014 Nov;35(11):11243-59. | ||||||||||
| Title: | Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies. | ||||||||||
| Author: | Wu, Kai-Ge|He, Xiao-Feng|Li, Yun-Hui|Xie, Wei-Bin|Huang, Xi | ||||||||||
| PMID: | 25113251 | ||||||||||
| 8. | |||||||||||
| Journal: | Sci Rep. 2014 Sep 11;4:6281. | ||||||||||
| Title: | Potentially functional polymorphisms in the ERCC2 gene and risk of esophageal squamous cell carcinoma in Chinese populations. | ||||||||||
| Author: | Zhu, Mei-Ling|He, Jing|Wang, MengYun|Sun, Meng-Hong|Jin, Li|Wang, Xiaofeng|Yang, Ya-Jun|Wang, Jiu-Cun|Zheng, Leizhen|Xiang, Jia-Qing|Wei, Qing-Yi | ||||||||||
| PMID: | 25209371 | ||||||||||
| 9. | |||||||||||
| Journal: | Ann Oncol. 2015 Apr;26(4):624-44. | ||||||||||
| Title: | A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage. | ||||||||||
| Author: | Findlay, J M|Middleton, M R|Tomlinson, I | ||||||||||
| PMID: | 25214541 | ||||||||||
| 10. | |||||||||||
| Journal: | Intern Med. 2015;54(3):251-9. | ||||||||||
| Title: | XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis. | ||||||||||
| Author: | Guo, Xu-Feng|Wang, Jun|Lei, Xiao-Fei|Zeng, Yan-Ping|Dong, Wei-Guo | ||||||||||
| PMID: | 25748732 | ||||||||||
| 11. | |||||||||||
| Journal: | Medicine (Baltimore). 2015 Sep;94(39):e1593. | ||||||||||
| Title: | Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis. | ||||||||||
| Author: | Qixing, Mao|Gaochao, Dong|Wenjie, Xia|Rong, Yin|Feng, Jiang|Lin, Xu|Mantang, Qiu|Qiang, Chen | ||||||||||
| PMID: | 26426637 | ||||||||||
| 12. | |||||||||||
| Journal: | Pharmacogenomics J. 2016 Jun;16(3):266-71. | ||||||||||
| Title: | Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study. | ||||||||||
| Author: | Boldrin, E|Rumiato, E|Fassan, M|Rugge, M|Cagol, M|Marino, D|Chiarion-Sileni, V|Ruol, A|Gusella, M|Pasini, F|Amadori, A|Saggioro, D | ||||||||||
| PMID: | 26054330 | ||||||||||